Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143)
Clinical trial NCT01335997 · TERMINATED
Trial details
- NCT number
- NCT01335997
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2012-01-01
- Enrollment
- 1139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.